The COVID-19 mRNA vaccines amply demonstrated the potential of nucleic acid-based medicines to reshape healthcare on a truly global basis. David McCall, Senior Editor, Nucleic Acid Insights, speaks to Robert Langer, David H Koch Institute Professor, Massachusetts Institute of Technology, about building on his enormous legacy as a founding father of nucleic acid delivery by enabling worldwide patient access to novel vaccines and therapeutics alike.
No takes yet. Share an insight, caveat, or question.
Róbert Langer (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: